We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Anti-VEGF Therapy or Vitrectomy Surgery for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy.
- Authors
Tan, Gavin Siew-Wei; Chakravarthy, Usha; Wong, Tien Yin
- Abstract
The authors reflect on a study which assessed the effectiveness of the anti-vascular endothelial growth factor (anti-VEGF) agent aflibercept versus vitrectomy with panretinal photocoagulation in treating patients with proliferative diabetic retinopathy with vitreous hemorrhage. Based on the results, it is recommended that patients should have access to early rescue vitrectomy surgery if aflibercept is used as initial treatment. Diabetic retinopathy is the leading cause of blindness.
- Subjects
DIABETIC retinopathy treatment; VASCULAR endothelial growth factor antagonists; VITRECTOMY; DIABETIC retinopathy; LIGHT coagulation; BLINDNESS
- Publication
JAMA: Journal of the American Medical Association, 2020, Vol 324, Issue 23, p2375
- ISSN
0098-7484
- Publication type
journal article
- DOI
10.1001/jama.2020.22829